Is ASAQ GPSC NAFDAC-registered?

Yes — our August 2026 copy of the NAFDAC Greenbook lists 3 ASAQ GPSC registrations, one per strength or presentation: Artesunate 25 mg + Amodiaquine 67.5 mg — A4-6250 (Active); Artesunate 50 mg + Amodiaquine 135 mg — A4-6251 (Active); Artesunate 100 mg + Amodiaquine 270 mg — A4-6252 (Active). Check the number printed on your pack against its own listing.

What is ASAQ GPSC used for?

ASAQ GPSC is a brand of Artesunate-Amodiaquine (Antimalarial (Artemisinin combination)). Treatment of uncomplicated Plasmodium falciparum malaria, confirmed by test where possible See the full Artesunate-Amodiaquine guide for dosage, side effects, and warnings.

ASAQ GPSC

An Artesunate-Amodiaquine brand by Guilin Pharmaceuticals Nigeria Limited — tablet, made in China.

NAFDAC registration

Our August 2026 copy of the NAFDAC Greenbook lists 3 ASAQ GPSC registrations — one per strength or presentation. Check the number on your pack against its own line:

Artesunate 25 mg + Amodiaquine 67.5 mgActive
A4-6250View this registration on the Greenbook →
Artesunate 50 mg + Amodiaquine 135 mgActive
A4-6251View this registration on the Greenbook →
Artesunate 100 mg + Amodiaquine 270 mgActive
A4-6252View this registration on the Greenbook →

Check “ASAQ GPSC” in the NAFDAC checker (shows every registration)

ASAQ GPSC at a glance

Generic name: Artesunate-Amodiaquine
Manufacturer: Guilin Pharmaceuticals Nigeria Limited
Form: Tablet
Available strengths: Artesunate 25 mg + Amodiaquine 67.5 mg· 3 makers Artesunate 50 mg + Amodiaquine 135 mg· 4 makers Artesunate 100 mg + Amodiaquine 270 mg· 3 makers
Made in: China
NAFDAC reg. no.: 3 registrations

ASAQ GPSC price in Nigeria

Prices for Artesunate-Amodiaquine products vary by brand, strength, and pack size — check current prices at a licensed pharmacy, or tell us what you need and we'll connect you with a verified source.

About Artesunate-Amodiaquine

Artesunate-Amodiaquine (often shortened to ASAQ, and known in Nigeria through brands like Camosunate and Diasunate) is one of the World Health Organization's first-line Artemisinin-based Combination Therapies (ACTs) for uncomplicated malaria — the same family as artemether-lumefantrine (Coartem), and its main alternative in Nigeria's national treatment guidelines.

Read the full Artesunate-Amodiaquine guide — dosage, side effects, warnings, and all registered brands.

Frequently asked questions

Registration details are shown exactly as recorded in the NAFDAC Greenbook (our copy: August 2026). Listings can lag renewals — always confirm current status on the official Greenbook before acting on it. Content updated August 2026.